Agion® Antimicrobial Technology and FOSSHIELD® Key Features of Nexera Medical’s Spectrashield 9500 Surgical N95 Respirator Mask, with Embedded Antibacterial Performance
Now commercially available in the U. S. as Nexera receives FDA 510(k) and NIOSH Clearance
WAKEFIELD, MA, APRIL 12, 2011 –Sciessent LLC, creator of ionic silver-based antimicrobial brands Agion® and Agion Active™, is pleased to announce the U.S. release of the Nexera Medical SpectraShieldTM model 9500 Surgical Respirator Mask using Foss Manufacturing’s FOSSHIELD® fibers treated with Agion antimicrobial technology. The mask recently received FDA 510(k) and NIOSH clearance, making it the first surgical respirator mask with embedded antibacterial performance to achieve FDA clearance in the United States.
“Considered the model for the next generation respirator mask, the SpectraShieldTM 9500 surgical respirator is equivalent to a N95 (NIOSH rating),” explains Paul Sallarulo, CEO of Nexera Medical. “The SpectraShieldTM 9500 surgical respirator mask begins to eliminate certain strains of bacteria immediately on contact. This is the first mask treated with both AgIon and FOSSHIELD technology to receive FDA and NIOSH approval, and we’re excited to introduce it to the U.S. market.”
Sciessent's customized Agion branded antimicrobial solutions incorporate silver ions in a zeolite carrier. The silver ions exchange with other positive ions (often sodium) from the moisture in the environment, effecting a release of silver “on demand.” Depending on the microorganism, Agion antimicrobial technology has been shown to initially reduce microbial populate ions within minutes to hours while maintaining optimal performance for years. FOSSHIELD® incorporates Agion antimicrobial technology in a fiber system to deliver effective protection from microbes for the life of the product. The fiber can be blended into almost any fabric from cotton to nylon without changing its characteristics.
“Independent testing in the United States and Europe has shown the mask’s ability to kill 99.99% of tested bacteria on the surface of the mask within an hour including Methicillin-resistant Staphylococcus aureus (MRSA), Streptococcus pyogenes and Haemophilus influenza,” said Paul Ford, CEO of Sciessent. “Sciessent has been steadily expanding our Agion technology into the medical device market, and we’re proud to partner on this innovative product with Foss and Nexera.”
Sciessent, located in Wakefield, Mass., is a leader in providing customized solutions that enhance the value of partners’ products. Sciessent’s Agion® , Agion Active™ and Lava™ brands are based on silver and other naturally occurring elements and have been incorporated into a wide range of consumer, industrial and healthcare products, including apparel, cell phones, footwear, keyboards, water filters, medical catheters and ice machines. Sciessent's customers include many leading brands such as Dell, Motorola, Columbia, Adidas, PPG, Carrier and DuPont.
For more information about Sciessent, please visitwww.sciessent.com;for the Agion brand, please visitwww.agion-tech.com andwww.agionactive.com and follow the Agion brand’s exciting consumer campaign onFacebook and/orTwitter